NT5E and graft versus host disease: As introduced above, ATP released at the sites of damage in allo-HSCT recipients promotes inflammation, but its degradation by apyrase can prevent GVHD [72] suggesting a beneficial role for the ecto-nucleotidases CD39 and CD73.